Merck & Co., Inc.’s (MRK) “Neutral” Rating Reiterated at Citigroup
Citigroup reaffirmed their neutral rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a report issued on Wednesday, MarketBeat Ratings reports. They currently have a $84.00 price target on the stock, down from their previous price target of $115.00. MRK has been the topic of a number of other reports. Cantor […]
Citigroup reaffirmed their neutral rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a report issued on Wednesday, MarketBeat Ratings reports. They currently have a $84.00 price target on the stock, down from their previous price target of $115.00. MRK has been the topic of a number of other reports. Cantor […]
